To estimate the excess mortality due to alcohol in England and Wales death rates specific to alcohol consumption that had been derived from five longitudinal studies were applied to the current population divided into categories of alcohol consumption. Because of the J shaped relation between alcohol consumption and death the excess mortality used as a baseline was an alcohol consumption of 1-10 units/ week and an adjustment was made for the slight excess mortality of abstainers. The number of excess deaths was obtained by subtracting the number of deaths expected if ali the population had the consumption ofthe lowest risk group; correction for the total observed mortality in the population was made. This resulted in an estimate of 28 000 deaths each year in England and Wales as the excess mortality among people aged 15-74 associated with alcohol consumption. determined in the early 1970s it is likely to be an underestimate.
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A report of the Royal College of Physicians gives a figure of 25 000 deaths a year related to alcohol,' based on a Swedish study of 8000 men in Malmo aged 46-48 who were followed up for three and a half to eight years.'0 During the follow up 218 died; 83% of these underwent necropsy, and one quarter of the deaths were found to be related to alcohol. If this rate is applied to men aged 35-64 in England and Wales the estimated number of deaths associated with alcohol is 17000.
The Royal College of General Practitioners gives a figure of40 000 excess deaths for adults (age 15 or over) in England and Wales.3 The figure was calculated by attributing a proportion of deaths within selected diagnoses to alcohol and then sumnming these deaths. The proportions of deaths were taken from several different studies. The Honolulu heart study was a study of cardiovascular disease in men of Japanese descent living in Hawaii: 8006 men aged 45-65 were recruited during 1965-8 and followed up for eight years.'" The quantity and frequency of alcohol consumption were measured and validated by 24 hour dietary recall. Death rates were adjusted by the direct method to represent the age structure (in five year groups) of the entire population. Multivariate analysis controlled for cigarette smoking, weight, systolic blood pressure, and serum cholesterol concentration; these factors made little difference to the association of alcohol intake with mortality.
The United Kingdom study of male civil servants recruited 1422 men aged 40-64 in London in 1967-9 and followed them up for 10 years.'6 Their alcohol consumption was obtained from a three day dietary record. Death rates were standardised for age of the total population by the direct method. Adjustment of these rates for smoking habit, diastolic blood pressure, plasma cholesterol concentration, and grade of employment made little difference to the relative risk of death according to alcohol consumption.
The Kaiser-Permanente study divided 8060 people BMJ VOLUME 297 1 OCTOBER 1988 (aged 15-79) according to alcohol consumption into four groups matched for age, sex, race, and cigarette smoking."' They had been recruited from multiphasic health examinations in California and were followed up for 10 years. Alcohol consumption was measured by the number of drinks of specific beverages per day over the previous year. Data were reported separately by sex, age, and smoking habit. The Chicago Western electric study was a study of coronary heart disease in 1832 men employed by the Western Electric Company.'8 They were aged 40-55 and free of coronary heart disease and were followed up for 17 years. The number of drinks of specific beverages per month was determined. Death rates 9-1 95% Confidence interval 9-0 to 11-2 6-9 to 9-0 6-9 to 10-2 4-7 to 13-5 were adjusted for the age of the total population. Adjustment for diastolic blood pressure, smoking habit and pulse rate made little difference to the relative risk of death according to alcohol consumption.
The Framingham study was a study of cardiovascular disease in 5209 men and women aged 29-62 in Framingham, Massachusetts.'9 They were first examined in 1948 and were followed up for 17 years. Alcohol consumption was obtained by estimating the average number of drinks of specific beverages per month. Death rates were adjusted for the age of the total population by the direct method. Adjustment for systolic blood pressure, cigarette consumption, relative weight, and serum lipoprotein concentrations made little difference to the relative risk of death according to alcohol consumption. Data were reported separately for men and women.
I converted the alcohol consumption of the different groups in the five studies to units of alcohol consumed per week (one unit contains 8 g ofabsolute alcohol) and calculated the death rates for men (table IV) and  women (table V) . As all five studies showed a J shaped relation between alcohol consumption and death (abstainers have higher death rates than those drinking 1-10 units per week) I used a consumption of 1-10 units per week as the baseline measurement and subtracted the excess deaths for abstainers from this figure. For example, to calculate the excess deaths associated with alcohol consumption among men aged 35-64 from the death rates in the study of civil servants I applied the proportions of drinkers found in Wilson's study'3 (table II) to the total population to give the number of men in England and Wales consuming specified amounts of alcohol. These population figures were multiplied by the death rates calculated from the study of civil servants.'6 The total number of estimated deaths was 57 809 (table VI) . The baseline, deaths in the consumption band 1-10 units, was 50220 (death rate multiplied by total population: in this example 6-2/100Ox8-1 million). The excess deaths for abstainers were 1568 (excess rate of (9 4-6 2)/1000= 3 2/1000 applied to 0-49 million abstainers); thus the excess mortality was 6021 (57 809-50 220-1568). As the actual number of deaths in 1985 among men aged 35-64 in England and Wales was 67 529 applying a correction factor of 1-16 (67 529/57 809) gave a total number of excess deaths of 7033 (67529-(50220 x I -168)-(1568 x 1 -168).
This calculation was made tor all five studies. Tables VII and VIII give the estimates of excess deaths derived from the different studies for men and for women, respectively, in the age range 35-64. The 95% confidence intervals for the estimated excess deaths were based on the 95% confidence intervals for the rates given in tables IV and V. The data from the Kaiser-Permanente study gave a total number ofexcess deaths of 28 178 -say 28 000-in England and Wales among people aged (table IX) .
Discussion
The estimates of the excess mortality associated with alcohol consumption provided in previous studies present several problems. The estimate presented in this paper is based on methods previously applied to ascertain the association between death and cigarette smoking."I Unfortunately there is no single basic study of the association of death with alcohol consumption so estimates were based on results from one British and four American studies.
The five studies used in my calculations have drawbacks. Firstly, four of the studies were carried out in the United States on populations differing in ethnic origin, social class, and employment state, all of which have independent effects on alcohol consumption and mortality. Data on mortality from these North American studies may not apply to populations in the United Kingdom. Secondly, a cohort phenomenon may limit the applicability of these studies. The risk related to alcohol consumption in populations derived 25 or so years ago may be different from that in current populations with the same alcohol consumption. Thirdly, four of the studies were studies of coronary heart disease; although they included an estimate of alcohol consumption, they were not designed to relate alcohol consumption to mortality. Finally, four of the five studies give little detail about risk for different age groups, providing data only for the range 35-64 years. Only the Kaiser-Permanente study provided adequate data for different age ranges.
An estimate of total excess deaths based on one study should increase the validity of this calculation. Based on the Kaiser-Permanente study the total excess mortality came to 28 000 deaths. This is an estimate of the association between alcohol consumption and mortality, not between alcohol consumption and specific diseases. Further longitudinal studies are needed to investigate the association of alcohol consumption with morbidity and mortality. These results for enalapril are reassuring and provide further evidence of the value of prescriptionevent monitoring.
Introduction
The angiotensin-converting enzyme inhibitor enalapril maleate was first marketed in general practice in the United Kingdom in April 1985. Arrangements were made immediately to conduct postmarketing surveillance by prescription-event monitoring, which has been developed by the Drug Safety Research Unit. The purpose of prescription-event monitoring is to identify and measure adverse effects of new drugs soon after their introduction into general practice.
Patients and methods
The method has been described elsewhere.' Briefly, prescription-event monitoring uses copies of NHS prescriptions as a means of identifying a patient, a
